Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3317566 | Pancreatology | 2012 | 8 Pages |
Abstract
These results suggest that combined treatment with sorafenib and celecoxib synergistically induce growth inhibition and apoptosis in pancreatic adenocarcinoma cells through a process involving p21WAF1/Cip1 suppression.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ann H. Rosendahl, Chinmay Gundewar, Katarzyna Said, Emelie Karnevi, Roland Andersson,